デフォルト表紙
市場調査レポート
商品コード
625826

米国のステントグラフトの市場:販売量、平均販売価格、将来予測

Stent Graft Market | US | Units Sold, Average Selling Prices, Forecasts | 2018-2024| MedCore

出版日: | 発行: iData Research Inc. | ページ情報: 英文 544 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.50円

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

米国のステントグラフトの市場:販売量、平均販売価格、将来予測
出版日: 2018年03月01日
発行: iData Research Inc.
ページ情報: 英文 544 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、米国国内のステントグラフトの市場について分析し、全体的な市場構造や製品構成、市場規模・収益額・成長率・平均価格の推移と見通し (過去4年間・今後7年間分)、主な市場促進・抑制要因、主要企業の概略・競争力などを調査すると共に、近年の企業間競争・資本取引の情勢などの情報を取りまとめてお届けいたします。

エグゼクティブ・サマリー

米国の末梢血管装置市場の概要

競争分析

市場の傾向

市場の発展

関連処置の実施件数

分析対象の処置コード

分析対象市場

主要レポートの更新状況

過去のバージョン

分析手法

  • IDATAの9段階の分析方法

疾患概要

  • 人体の基本構造
  • 疾患の概要
    • 大動脈瘤
    • アテローム性動脈硬化
    • 末梢動脈疾患 (PAD)
    • 深部静脈血栓症 (DVT)
    • 肺塞栓症 (PE)
  • 患者の人口構成
    • 大動脈瘤
    • アテローム性動脈硬化
    • 末梢動脈疾患 (PAD)
    • 深部静脈血栓症 (DVT)
    • 肺塞栓症 (PE)

ステントグラフトの市場

  • イントロダクション
  • 市場概要
  • 市場の分析と予測
    • ステントグラフト市場:全体
    • 腹部大動脈瘤 (AAA) 向けステントグラフト市場:全体
    • 有窓性ステントグラフト市場:全体
    • 胸部大動脈瘤 (TAA) 向けステントグラフト市場
  • 市場促進・抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 企業別市場シェアの分析

略語一覧

付録:企業のプレスリリース

図表

LIST OF CHARTS

  • Chart 1 1: Peripheral Vascular Device Market by Segment, U.S., 2014 - 2024 3
  • Chart 1 2: Peripheral Vascular Device Market Overview, U.S., 2017 & 2024 3
  • Chart 3 1: Stent Graft Market by Segment, U.S., 2014 - 2024 58
  • Chart 3 2: Stent Graft Market Breakdown, U.S., 2017 59
  • Chart 3 3: Stent Graft Market Breakdown, U.S., 2024 59
  • Chart 3 4: Total Stent Graft Market, U.S., 2014 - 2024 61
  • Chart 3 5: AAA Stent Graft Market by Segment, U.S., 2014 - 2024 64
  • Chart 3 6: Total AAA Stent Graft Market, U.S., 2014 - 2024 65
  • Chart 3 7: Bifurcated Main Body Graft Market, U.S., 2014 - 2024 67
  • Chart 3 8: Contralateral/Ipsilateral Iliac Leg/Limb Market, U.S., 2014 - 2024 69
  • Chart 3 9: Aorto-uni-iliac (AUI) Stent Graft Market, U.S., 2014 - 2024 71
  • Chart 3 10: Iliac Extension Market, U.S., 2014 - 2024 73
  • Chart 3 11: Aortic Extension Market, U.S., 2014 - 2024 75
  • Chart 3 12: Fenestrated Stent Graft Market by Segment, U.S., 2014 - 2024 78
  • Chart 3 13: Total Fenestrated Stent Graft Market, U.S., 2014 - 2024 79
  • Chart 3 14: Fenestrated Distal Bifurcated Graft Market, U.S., 2014 - 2024 81
  • Chart 3 15: Fenestrated Proximal Body Graft Market, U.S., 2014 - 2024 83
  • Chart 3 16: TAA Stent Graft Market, U.S., 2014 - 2024 86
  • Chart 3 17: Leading Competitors, Stent Graft Market, U.S., 2017 93
  • Chart 3 18: Leading Competitors, AAA Stent Graft Market, U.S., 2017 95

LIST OF FIGURES

  • Figure 1 1: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2017 (1 of 4) 5
  • Figure 1 2: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2017 (2 of 4) 5
  • Figure 1 3: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2017 (3 of 4) 5
  • Figure 1 4: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2017 (4 of 4) 7
  • Figure 1 5: Companies Researched in this Report, U.S., 2017 8
  • Figure 1 6: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (1 of 4) 9
  • Figure 1 7: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (2 of 4) 10
  • Figure 1 8: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (3 of 4) 11
  • Figure 1 9: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (4 of 4) 12
  • Figure 1 10: Recent Events in the Peripheral Vascular Device Market, U.S., 2014 - 2017 13
  • Figure 1 11: Peripheral Vascular Procedures Covered, U.S., 2017 (1 of 5) 14
  • Figure 1 12: Peripheral Vascular Procedures Covered, U.S., 2017 (2 of 5) 15
  • Figure 1 13: Peripheral Vascular Procedures Covered, U.S., 2017 (3 of 5) 16
  • Figure 1 14: Peripheral Vascular Procedures Covered, U.S., 2017 (4 of 5) 17
  • Figure 1 15: Peripheral Vascular Procedures Covered, U.S., 2017 (5 of 5) 18
  • Figure 1 16: Procedure Codes Investigated, U.S., 2017 (1 of 2) 19
  • Figure 1 17: Procedure Codes Investigated, U.S., 2017 (2 of 2) 20
  • Figure 1 18: Peripheral Vascular Device Markets Covered, U.S., 2017 (1 of 6) 21
  • Figure 1 19: Peripheral Vascular Device Markets Covered, U.S., 2017 (2 of 6) 22
  • Figure 1 20: Peripheral Vascular Device Markets Covered, U.S., 2017 (3 of 6) 23
  • Figure 1 21: Peripheral Vascular Device Markets Covered, U.S., 2017 (4 of 6) 24
  • Figure 1 22: Peripheral Vascular Device Markets Covered, U.S., 2017 (5 of 6) 25
  • Figure 1 23: Peripheral Vascular Device Markets Covered, U.S., 2017 (6 of 6) 26
  • Figure 1 24: Key Report Updates (1 of 5) 27
  • Figure 1 25: Key Report Updates (2 of 5) 28
  • Figure 1 26: Key Report Updates (3 of 5) 29
  • Figure 1 27: Key Report Updates (4 of 5) 30
  • Figure 1 28: Key Report Updates (5 of 5) 31
  • Figure 1 29: Version History 32
  • Figure 3 1: Stent Graft Market by Segment, U.S., 2014 - 2024 (US$M) 57
  • Figure 3 2: Total Stent Graft Market, U.S., 2014 - 2024 60
  • Figure 3 3: AAA Stent Graft Market by Segment, U.S., 2014 - 2024 (US$M) 63
  • Figure 3 4: Total AAA Stent Graft Market, U.S., 2014 - 2024 65
  • Figure 3 5: Bifurcated Main Body Graft Market, U.S., 2014 - 2024 66
  • Figure 3 6: Contralateral/Ipsilateral Iliac Leg/Limb Market, U.S., 2014 - 2024 68
  • Figure 3 7: Aorto-uni-iliac (AUI) Stent Graft Market, U.S., 2014 - 2024 70
  • Figure 3 8: Iliac Extension Market, U.S., 2014 - 2024 72
  • Figure 3 9: Aortic Extension Market, U.S., 2014 - 2024 74
  • Figure 3 10: Fenestrated Stent Graft Market by Segment, U.S., 2014 - 2024 (US$M) 76
  • Figure 3 11: Total Fenestrated Stent Graft Market, U.S., 2014 - 2024 79
  • Figure 3 12: Fenestrated Distal Bifurcated Graft Market, U.S., 2014 - 2024 80
  • Figure 3 13: Fenestrated Proximal Body Graft Market, U.S., 2014 - 2024 82
  • Figure 3 14: TAA Stent Graft Market, U.S., 2014 - 2024 85
  • Figure 3 15: Drivers and Limiters, Stent Graft Market, U.S., 2017 89
  • Figure 3 16: Leading Competitors, Stent Graft Market, U.S., 2017 93
  • Figure 3 17: Leading Competitors, AAA Stent Graft Market, U.S., 2017 94
  • Figure 5 1: Press Release Summary 99
目次
Product Code: iDATA_USPV18_MC_STG

The total U.S. market for stent grafts includes three segments: the abdominal aortic aneurysm (AAA) stent graft segment, the fenestrated stent graft segment and the thoracic aortic aneurysm (TAA) stent graft segment.

Growth in the unit sales of the AAA, fenestrated and TAA stent graft segments will drive growth in the value of the total market as the forecast period progresses. New screening techniques and patient awareness, combined with new technology characterized by lower-profile, more user-friendly devices, are leading to increased unit sales.

Table of Contents

TABLE OF CONTENTS I

LIST OF FIGURES XIX

LIST OF CHARTS XXI

EXECUTIVE SUMMARY 1

U.S. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 9

MARKET DEVELOPMENTS 13

PROCEDURE NUMBERS 14

PROCEDURE CODES INVESTIGATED 19

MARKETS INCLUDED 21

KEY REPORT UPDATES 27

VERSION HISTORY 32

RESEARCH METHODOLOGY 33

    • Step 1: Project Initiation & Team Selection 33
    • Step 2: Prepare Data Systems and Perform Secondary Research 36
    • Step 3: Preparation for Interviews & Questionnaire Design 37
    • Step 4: Performing Primary Research 38
    • Step 5: Research Analysis: Establishing Baseline Estimates 40
    • Step 6: Market Forecast and Analysis 41
    • Step 7: Identify Strategic Opportunities 43
    • Step 8: Final Review and Market Release 44
    • Step 9: Customer Feedback and Market Monitoring 45

DISEASE OVERVIEW 46

  • 2.1 BASIC ANATOMY 46
  • 2.2 DISEASE OVERVIEW 47
    • 2.2.1 Aortic Aneurysms 47
    • 2.2.2 Atherosclerosis 48
    • 2.2.3 Peripheral Arterial Disease (PAD) 48
    • 2.2.4 Deep Vein Thrombosis (DVT) 49
    • 2.2.5 Pulmonary Embolism (PE) 50
  • 2.3 PATIENT DEMOGRAPHICS 52
    • 2.3.1 Aortic Aneurysms 52
    • 2.3.2 Atherosclerosis 53
    • 2.3.3 Peripheral Arterial Disease (PAD) 53
    • 2.3.4 Deep Vein Thrombosis (DVT) 53
    • 2.3.5 Pulmonary Embolism (PE) 54

STENT GRAFT MARKET 55

  • 3.1 INTRODUCTION 55
  • 3.2 MARKET OVERVIEW 57
  • 3.3 MARKET ANALYSIS AND FORECAST 60
    • 3.3.1 Total Stent Graft Market 60
    • 3.3.2 Total AAA Stent Graft Market 62
      • 3.3.2.1 Bifurcated Main Body Graft Market 66
      • 3.3.2.2 Contralateral/Ipsilateral Iliac Leg/Limb Market 68
      • 3.3.2.3 Aorto-uni-iliac (AUI) Stent Graft Market 70
      • 3.3.2.4 Iliac Extension Market 72
      • 3.3.2.5 Aortic Extension Market 74
    • 3.3.3 Total Fenestrated Stent Graft Market 76
      • 3.3.3.1 Fenestrated Distal Bifurcated Graft Market 80
      • 3.3.3.2 Fenestrated Proximal Body Graft Market 82
    • 3.3.4 TAA Stent Graft Market 84
  • 3.4 DRIVERS AND LIMITERS 87
    • 3.4.1 Market Drivers 87
    • 3.4.2 Market Limiters 89
  • 3.5 COMPETITIVE MARKET SHARE ANALYSIS 90

ABBREVIATIONS 96

APPENDIX: COMPANY PRESS RELEASES 99